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Background: Promoting quality of life (QoL) is a key priority in cancer care. We investigated the hypothesis that,
in comparison to usual care, exercise post-neoadjuvant chemoradiation therapy/prior to surgical resection will
reduce pain, fatigue, and insomnia, and will improve physical and mental health perceptions in patients with
locally advanced stage rectal cancer.
Methods: In this non-randomized controlled pilot trial, patients in the supervised exercise group (EG; Mage = 64 years;
64% male) and in the control group (CG; Mage = 72 years; 69% male) completed the European Organization for
Research and Treatment of Cancer core Quality of Life questionnaire and the RAND 36-Item Health Survey three
times: pre-neoadjuvant chemoradiation therapy (Time 1; nEC = 24; nCG = 11), post-neoadjuvant chemoradiation
therapy/pre-exercise intervention (Time 2; nEC = 23; nCG = 10), and post-exercise intervention (Time 3; nEC = 22;
nCG = 10). The 6-week exercise intervention was delivered in hospital and comprised of interval aerobic training.
Patients trained in pairs three times per week for 30 to 40 min. Data were analyzed by Mann–Whitney tests and
by Wilcoxon matched-pairs signed-rank tests.
Results: No significant between-group differences in changes were found for any of the outcomes. In both groups,
fatigue levels decreased and physical health perceptions increased from pre- to post-exercise intervention. Pain
levels also decreased from pre- to post-exercise intervention, albeit not significantly.
Conclusions: The findings from this study can be used to guide a more definitive trial as they provide preliminary
evidence regarding the potential effects of pre-operative exercise on self-reported pain, fatigue, insomnia, and
health perceptions in patients with locally advanced rectal cancer. Trial registration: This study has been registered
with clinicaltrials.gov (NCT01325909; March 29, 2011).
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Approximately 813,613 men and 663,689 women were
diagnosed with rectal cancer worldwide in 2012 [1]. Of
these, 50–65% were diagnosed with locally advanced rectal
cancer. Treatment for locally advanced rectal cancer often
involves neoadjuvant chemoradiation therapy followed by
surgical resection with the aim of improving resectability
and disease control [2]. Although these standard treat-
ments can prolong survival, they can result in adverse
physical side effects, including pain, fatigue, constipation
or diarrhea, upset stomach, nausea, sexual problems,
infertility, acute toxicity, and decreased physical fitness
[3, 4]. They can also result in adverse psychological side
effects, including anxiety and distress [5]. As a result of
these treatment-related side effects, patients’ quality of life
(QoL) is often impaired [6]. Considering that QoL is a sig-
nificant prognostic factor for cancer recurrence and all-
cause mortality in patients with advanced colorectal can-
cer [7], identifying therapies to reduce treatment-related
side effects and enhance QoL is a priority in the care of
patients with advanced rectal cancer.
Exercise is one type of therapy that may improve out-
comes for patients with advanced cancer at different
stages of the disease trajectory. For example, researchers
have reported that post-operative exercise can prolong
survival after cancer diagnosis [8, 9], as well as enhance
QoL by helping patients with advanced stage cancer
manage physical and psychological side effects [10]. In
addition, researchers have reported that pre-operative ex-
ercise is beneficial for patients with colorectal [11], colon
[12, 13], and rectal cancer [14]. Specifically, they have
shown that it can improve cardiorespiratory fitness [14],
muscle strength [14], peak power output [13], heart rate
[13], oxygen uptake [13], and respiratory muscle endur-
ance [12]. This provides evidence that pre-operative exer-
cise can elicit favourable changes in physiological
outcomes in patients with advanced stage cancer [15, 16].
However, limited data are currently available to deter-
mine the effects of exercise post-neoadjuvant chemora-
diation therapy and prior to surgical resection on key
patient-reported outcomes (e.g., pain, fatigue, insomnia,
health perceptions) in patients with advanced rectal
cancer. Considering that advanced rectal cancer and
neoadjuvant chemoradiation therapy can adversely affect
patients’ general physical and mental health perceptions
and increase fatigue, pain, and insomnia [17, 18], which
can negatively affect recovery [5], it is important to
examine whether participating in pre-operative exercise
can help prevent or reduce these adverse consequences
reported by patients.
The present study
We delivered a 6-week exercise intervention to patients
diagnosed with locally advanced rectal cancer immediatelypost-neoadjuvant chemoradiation therapy and prior to
surgical resection in order to examine the benefits of ex-
ercise at this particular stage of the disease trajectory.
We examined changes in various patient-reported out-
comes resulting from the exercise intervention using
quantitative and qualitative methods. The aim of our
qualitative inquiry was to capture in-depth accounts of
changes in QoL associated with the exercise intervention
from patients’ perspectives [19]. We had several aims in
mind for our quantitative inquiry. Herein, we focus on
the two aims related to changes in QoL. The first aim
was to assess the effects of the exercise intervention on
indicators of QoL in comparison to usual care (i.e., as-
sess differences in changes between groups). The second
aim was to quantify the extent to which the exercise
intervention had a positive effect on indicators of QoL
(i.e., assess within-group changes). We focused on pain,
fatigue, insomnia, and physical and mental health per-
ceptions as indicators of QoL because (i) patients with
rectal cancer report these as main concerns [17], (ii)
these symptoms appear in the National Institute of
Health call for more efforts toward symptom manage-
ment in cancer [20], and (iii) they represent different di-
mensions of health relevant to patients with cancer [21].
Methods
Data analyzed for this study were collected as part of a
single-site, non-randomized controlled pilot trial. We
have published analyses using this sample elsewhere
[22, 23]. Additional details of the methods that are not
relevant to this study can be found in those publica-
tions. The protocol was approved by the North West –
Liverpool East Committee for Research Ethics (11/
H1002/12) and it was registered with clinicaltrials.gov
(NCT01325909; March 29, 2011). Patients provided
informed consent to participate in this study prior to us
conducting any study-related procedures.
Participants and procedures
From March 2011 to February 2013, patients referred to
the colorectal multidisciplinary team were recruited for
this study. Inclusion criteria were: (i) ≥ 18 years of age,
(ii) confirmed diagnosis of magnetic resonance imaging
defined locally advanced circumferential margin threat-
ened resectable rectal cancer (i.e., ≥ stage T2/N+ with
no distant metastasis), (iii) scheduled for standardized
neoadjuvant chemoradiation therapy, and (iv) perform-
ance status score of ≤ 2 on the Eastern Co-operative
Oncology Group (ECOG)/World Health Organization
(WHO) system [24]. Patients were not eligible if they:
(i) were unable to give informed consent, (ii) had been
diagnosed with non-resectable cancer, (iii) were unable
to perform a cardiopulmonary exercise test (CPET) or
exercise, (iv) had declined surgery or neoadjuvant
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standard neoadjuvant chemoradiation therapy.
All patients in this study underwent 5 weeks of
standardized neoadjuvant chemoradiation therapy. Stan-
dardized radiotherapy consisted of 45 Gray (Gy) in 25
fractions on weekdays using a three-dimensional con-
formal technique with computerized tomography guid-
ance. A booster dose was given (5.4 Gy in 3 fractions) to
the primary tumour only. Oral capecitabine at a dose of
825 mg.m−2 was given twice daily on radiotherapy days.
No patient received brachytherapy.
After completing neoadjuvant chemoradiation therapy,
all patients were assigned to the exercise group by
default (i.e., there was no allocation concealment) by the
colorectal multidisciplinary team unless they were un-
able to commit to the exercise schedule or lived > 15
miles from the hospital. These latter patients were asked
to act as contemporaneously recruited controls. A total
of 39 patients were recruited into the study, though four
dropped out immediately. Thirty-five patients completed
QoL assessments prior to receiving neoadjuvant chemo-
radiation therapy (Time 1 data analyzed) and went on to
receive neoadjuvant chemoradiation therapy. Thereafter,11 were allo
standardize
39 patients recruited
35 completed baseline CPET and Qo
assessments 
(Time 1 data analyzed )
35 received 5 weeks of standardize
neoadjuvant chemoradiation therap
23 completed CPET and 23 completed QoL 
assessments at week 0 
(Time 2 data analyzed)
22 completed 
CPET at week 3
24 were allocated to the exercise group
post-standardized neoadjuvant 
chemoradiation therapy 






22 completed CPET and 22 completed QoL 
assessments at week 6 




Fig. 1 Flow chart of recruitment and participation in this study24 were allocated to the exercise group and 11 to the
control group, though 1 patient switched immediately to
the control group. At this time, 23 patients in the
exercise group and 10 patients in the control group
completed QoL assessments prior to the 6-week exercise
intervention (Time 2 data analyzed). After the exercise
intervention, 22 patients remained in the exercise group
and completed QoL assessments along with 10 patients
in the control group (Time 3 data analyzed). Figure 1
displays the flow of patients through each stage of this
study from enrolment to analysis. We note that the sam-
ple size for analysis herein is slightly different from pre-
vious publications [22, 23] due to the completeness of
relevant data (i.e., the previous publications used CPET
data and the current study used QoL data).
Study procedures
Assessments
Patients completed questionnaires prior to neoadjuvant
chemoradiation therapy (Time 1), before starting the
exercise intervention (i.e., immediately post-neoadjuvant
chemoradiation therapy; Time 2), and immediately post-
exercise intervention (Time 3). They also underwent acated to the control group post-





Dropouts (n = 2):
2 declined repeated CPET 
and 2 gave no reason
 CPET and 10 completed QoL 
sessments at week 0
ime 2 data analyzed)
13 completed 
CPET at week 3
1 switched from the 
exercise group to the 
control group after 1 
session 
1 switched from the 
exercise group to the 
control group 
 CPET and 10 completed QoL
sessments at week 6
ime 3 data analyzed)
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spiratory, and skeletal muscle systems (see [25] for
protocol details) at these three time points1; however, an
additional CPET was performed mid-way through the
exercise intervention so as to modify the exercise pre-
scription according to patients’ changing fitness levels.
Prior to receiving the exercise intervention, patients re-
ceived usual care from their oncology care team.
Exercise intervention
The exercise protocol was progressive and lasted
6 weeks. Patients exercised in pairs three times per
week under the supervision of a trained exercise spe-
cialist in a hospital. Initially, exercise intensities were
tailored for each patient based on his/her standardized
CPET results post-chemoradiation therapy and modi-
fied thereafter according to his/her results mid-way
through the exercise intervention. Each patient was
instructed to engage in interval training on an electro-
magnetically braked cycle ergometer (Optibike Ergoline
GmbH, Germany). A chip-and-pin card with patients’
pre-loaded target interval intensities was used to en-
sure they engaged in 3 min of moderate-intensity inter-
vals (i.e., work rate of 80% of oxygen uptake at lactate
threshold) interspersed with 2 min of vigorous-
intensity intervals (i.e., work rate of 50% of the differ-
ence in work rates between peak oxygen uptake and
oxygen uptake at lactate threshold). For the first three
sessions, training consisted of a total time of 30 min,
which was then increased to 40 min for the rest of the
training sessions. All sessions included 5 min of warm-
up and 5 min of cool-down.
Outcome measures
At each of the three time points, we used the European
Organization for Research and Treatment of Cancer
30-item core Quality of Life questionnaire (EORTC
QOL-C30) version 3 [26] to assess patients’ levels of
pain, fatigue, and insomnia, and used the RAND 36-
Item Health Survey [27] to assess their general physical
and mental health perceptions.
The EORTC QLQ-C30 is a self-report questionnaire
developed to assess cancer patients’ QoL. It comprises
five multi-item functional subscales (i.e., role, physical,
cognitive, emotional, and social functioning), three
multi-item symptom scales (i.e., fatigue, pain, and nau-
sea), five single items assessing common symptoms ex-
perienced (i.e., dyspnea, insomnia, appetite loss,
constipation, and diarrhea), and two questions assessing
global health status/QoL. Each item has four response
options: (1) not at all, (2) a little, (3) quite a bit, and (4)
very much, except for the two questions assessing global
health status/QoL [response options range from (1) very
poor to (7) excellent]. Higher scores on the functionalsubscales and global health status/QoL scale represent a
better level of functioning and global health status/QoL,
whereas higher scores on symptom subscales represent
higher levels of symptomatology. Given that cancer
and neoadjuvant chemoradiation therapy can increase
fatigue, pain, and insomnia [17, 18], which can nega-
tively affect recovery [5], these scales were the focus of
the current analyses.
The RAND 36-Item Health Survey is a self-report
questionnaire that consists of eight subscales assessing
the health domains of physical functioning, social func-
tioning, role limitations due to physical health problems,
role limitations due to emotional health problems, vital-
ity/energy, bodily pain, general health perceptions, and
mental health perceptions. It includes the same items as
those in the 36-item Short-Form (SF-36) Health Survey
[28]; however, each item is scored on a scale ranging
from 0 to 100. Scores on the physical functioning, role
limitations due to physical health problems, bodily pain,
and general health perceptions subscales were averaged
into a physical component summary score. Scores on
the social functioning, role limitations due to emotional
health problems, vitality/energy, and mental health sub-
scales were averaged into a mental component summary
score. Higher scores represent better physical and men-
tal health perceptions.
Statistical analysis
All statistical analyses were performed using SPSS
version 23 and included all data available at any given
point. Missing values were not imputed for analysis. De-
scriptive data were used to describe differences on the
QoL measures across time points, and are expressed as
medians and inter-quartile ranges at each time point.
As the distribution of the variables was significantly dif-
ferent from normal based on Kolmogorov-Smirnov
tests for three variables (i.e., pain, insomnia, and mental
health perceptions), non-parametric tests were used.
Specifically, Mann–Whitney tests were used to assess
whether changes in fatigue, pain, insomnia, and health
perceptions across time points differed between the
exercise group and the control group (i.e., Aim 1; assess
differences in changes between the two groups). Wilcoxon
matched-pairs signed-rank tests were used to identify
any changes in fatigue, pain, insomnia, and health per-
ceptions across time points within-groups (i.e., Aim 2;
assess within-group changes). Of note, testing using
parametric tests (i.e., t-tests) for variables with normal
distributions yielded results similar to those obtained
with the non-parametric tests (data not shown). To
correct for multiple comparisons, we used the Simes
procedure [29] – a modification of the Bonferroni cor-
rection method. Accordingly, level of statistical signifi-
cance was set to p < .017.
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Patients in the exercise group had a mean age of 64 years
(range = 45 – 82), 64% were male, and they had a mean
body mass index of 27.4 kg/m2 (SD = 5.1). Forty-five
percent were currently smoking, and 46% had a past
medical history of diabetes, health failure, or ischemic
heart disease. Most (82%) scored ‘0’ on the ECOG/
WHO system meaning that they were asymptomatic
(i.e., fully active and able to carry on all pre-disease
activities without restriction). The rest (18%) scored ‘1’
meaning they were symptomatic but completely ambu-
latory (i.e., restricted in physically strenuous activity
but ambulatory and able to carry out work of a light or
sedentary nature). No patient scored ‘2’ meaning none
were symptomatic (i.e., <50% in bed during the day,
ambulatory and capable of all self care but unable to
carry out any work activities, and up and about > 50%
of waking hours). Overall, patients adhered well to the
exercise protocol, as the mean (SD) attendance for the
patients who took part in the exercise intervention was
96% (5.0). There were no adverse events reported.
Patients in the control group had a mean age of
72 years (range = 62 – 84), 69% were male, and they
had a mean body mass index of 24.9 kg/m2 (SD = 3.9).
Thirty-one percent were currently smoking, and 54%
had a past medical history of diabetes, health failure, or
ischemic heart disease. Most (62%) scored ‘0’ on the
ECOG/WHO, 23% scored ‘1’, and 15% scored ‘2’.Aim 1: Examining differences in changes between groups
There was no evidence that changes in pain (p = .67),
fatigue (p = .10), insomnia (p = .89), physical health
perceptions (p = .34), and mental health perceptions
(p = .90) observed from pre- to post-exercise interven-
tion differed significantly between the exercise group
and the control group.Table 1 Summary of scores for each group by time point expressed
Pain Fatigue
Baseline
Control (n = 11) 0 (0,33.0) 11.0 (11.1,44.0)
Intervention (n = 24) 16.7 (0,33.3) 27.5 (11.0,50.3)
Total (n = 35) 17.0 (0,33.0) 22.0 (11.0,44.0)
Pre-exercise intervention
Control (n = 10) 33.0 (29.0,62.5) 33.0 (19.3,49.8)
Intervention (n = 23) 33.0 (17.0,50.0) 33.0 (22.0,67.0)
Total (n = 33) 33.0 (17.0,50.0) 33.0 (22.0,67.0)
Post-exercise intervention
Control (n = 10) 8.5 (0,41.5) 22.0 (0,35.8)
Intervention (n = 22) 8.5 (0,37.3) 22.0 (11.0,33.0)
Total (n = 32) 8.5 (0,33.0) 22.0 (2.3,33.0)Aim 2: Examining within-group changes
Prior to neoadjuvant chemoradiation therapy, median
scores of pain, fatigue, and insomnia were 17.0, 22.0,
and 33.0 for the total sample, respectively, which are
comparable to published norms [30]. Median scores
were 52.8 and 56.8 for physical and mental health per-
ceptions, respectively, which also fall close to normative
values [31]. Descriptive statistics for all outcomes for
the exercise group and the control group by time point
are presented in Table 1.
Pain
There were changes in levels of pain from pre- to post-
neoadjuvant chemoradiation therapy (ps < .03), wherein
patients in both groups reported more pain immediately
post-neoadjuvant chemoradiation therapy compared to
pre-neoadjuvant chemoradiation therapy. Whereas pa-
tients in both groups reported less pain post-exercise inter-
vention, these were not statistically different from those
pre-exercise intervention (ps > .14).
Fatigue
There were changes in levels of fatigue from pre- to
post-neoadjuvant chemoradiation therapy (ps < .001) and
from pre- to post-exercise intervention (ps < .01). Specific-
ally, patients in both groups reported more fatigue immedi-
ately post-neoadjuvant chemoradiation therapy compared
to pre-neoadjuvant chemoradiation therapy, and reported
less fatigue post-exercise intervention compared to pre-
exercise intervention.
Insomnia
There were changes in levels of insomnia for patients in
the control group from pre- to post-neoadjuvant chemo-
radiation therapy (p = .05) and from pre- to post-exercise
intervention (p = .04), albeit not significantly based on
the corrected critical p-value. These patients reportedas medians and inter-quartile ranges
Insomnia Physical health Mental health
0 (0,33.0) 52.8 (32.8,64.4) 59.0 (53.3,63.4)
33.3 (0,67.0) 53.1 (33.5,63.1) 56.0 (51.3,63.4)
33.0 (0,67.0) 52.8 (33.0,63.4) 56.8 (51.8,63.4)
33.0 (0,42.5) 29.6 (24.4,34.7) 52.0 (43.3,61.3)
33.0 (33.0,67.0) 39.2 (26.6,55.2) 57.0 (51.3,62.4)
33.0 (16.5,67.0) 36.4 (26.4,53.3) 55.0 (50.3,61.7)
0 (0,49.8) 56.8 (30.7,64.1) 55.1 (51.2,58.6)
33.0 (0,67.0) 57.3 (37.3,63.1) 56.1 (53.5,60.7)
16.5 (0,67.0) 57.3 (37.1,63.3) 55.5 (53.0,59.5)
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diation therapy compared to pre-neoadjuvant chemora-
diation therapy, and reported less insomnia post-
exercise intervention compared to pre-exercise inter-
vention. There were no significant differences in levels
of insomnia across time points (ps ≥ .26) for patients
in the exercise group.
Physical health
There were changes in physical health perceptions
from pre- to post-neoadjuvant chemoradiation ther-
apy (ps < .007) and from pre- to post-exercise inter-
vention (ps < .004). Patients in both groups reported
poorer physical health perceptions immediately
post-neoadjuvant chemoradiation therapy compared to
pre-neoadjuvant chemoradiation therapy, and better
physical health perceptions post-exercise intervention
compared to pre-exercise intervention.
Mental health
There were no changes in mental health perceptions
across time points for either of the groups (ps ≥ .43).
Discussion
The wait period between the completion of neoadjuvant
chemoradiation therapy and prior to surgery can be
challenging for patients with advanced rectal cancer.
Debilitating side effects can impair recovery and reduce
QoL in this population [5]. Yet, relatively few studies
have been conducted to examine whether pre-operative
exercise is an effective approach to help patients manage
treatment-related side effects and promote QoL during
this time. In this study, we explored the effects of a 6-
week exercise intervention on pain, fatigue, insomnia,
and health perceptions in patients with locally advanced
cancer who had recently completed neoadjuvant chemo-
radiation therapy.
We found no evidence that an exercise intervention
delivered in hospital and that comprised of interval
aerobic training resulted in greater effects for any of the
outcomes in comparison to usual care, and thus failed to
support the notion that this type of exercise intervention
is more effective than usual care for reducing treatment-
related side effects and improving QoL. However, it is
important to note that our study procedures may explain
these findings. In the current study, all patients were
assigned to the exercise group by default, unless they
were unable to commit to the exercise schedule or
lived > 15 miles from the hospital. In retrospect, present-
ing patients in the control group with the exercise inter-
vention could have prompted them to reflect on their
current behaviour, made them recognize that there is a
need to change their behaviour, and in some cases, led
them to make changes to it. Indeed, patients in bothgroups increased their average number of steps from
pre- to post-exercise intervention (see [22], Figure 4).
Thus, this may have led to an under-estimation of the
effects of the exercise intervention in comparison to
usual care. With this in mind, we believe that there are
potentially some patients that may not need this type of
pre-operative intervention to manage their treatment-
related side effects and improve their QoL as they may
be active on their own. Observed improvements for the
control group may also be explained by other factors.
For example, those in the control group may have
sought other types of treatments (e.g., pharmaceuticals,
psychological therapy, group therapy), which could have
had positive effects on the outcomes we assessed. To
control for this, we recommend conducting a random-
ized controlled trial in which participation in various
therapies and exercise is measured and controlled for.
We are currently conducting a randomized controlled
trial (NCT01914068) in order to mitigate these study
design limitations.
Whilst our findings do not support the notion that
this type of exercise intervention is more effective than
usual care in reducing treatment-related side effects
and improving QoL, they demonstrate the likely value of
exercise post-neoadjuvant chemoradiation therapy/prior
to surgery for patients with advanced rectal cancer. This
is because we observed a significant improvement in
physical health perceptions and a decrease in levels of
fatigue post-exercise intervention for patients in the ex-
ercise group. Moreover, we noted decreases in levels of
pain post-exercise intervention for these patients,
though these did not reach statistical significance.
Previous observational and experimental studies have
demonstrated that post-operative exercise reduces fa-
tigue in adults with cancer [10, 32]. Our findings extend
these observations, demonstrating that a pre-operative
exercise intervention can decrease fatigue – which
happens to be the most frequent symptom cited [17] –
in a group of patients who had completed neoadjuvant
chemoradiation therapy for advanced stage rectal cancer.
This finding is important when considering that patients’
levels of fatigue significantly increased after neoadjuvant
chemoradiation therapy, and that fatigue can negatively
affect QoL more than any other symptom such as vomit-
ing, nausea, pain, and depression [33, 34]. While the
exact process through which exercise reduced patients’
levels of fatigue remains to be determined, it could be
that it helped to restore their physical capacity and fit-
ness [35]. Indeed, for patients in the exercise group, their
oxygen uptake at lactate threshold significantly improved
post-exercise intervention (data reported elsewhere;
[22]). Thus, future research attempting to determine
which aspects of pre-operative exercise helps to
reduce fatigue would be beneficial to optimize pre-
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tigue in this population.
Although we did not observe a statistically significant
difference in change between groups, we observed that
exercise post-neoadjuvant chemoradiation therapy signifi-
cantly improved patients’ physical health perceptions. This
finding is consistent with previous studies in which pa-
tients receiving treatment for either a primary, recurrent
incurable cancer or advanced cancer showed improve-
ments in health perceptions post-exercise [36–38]. These
findings are significant because decreases in physical
health are common during the post-neoadjuvant chemo-
radiation therapy period [3, 33, 34] and lead to more ad-
verse surgical outcomes (e.g., prolonged hospital stay;
[39]). Moreover, this may have clinical significance be-
cause self-rated health is a significant predictor of survival
in adults with advanced cancer [40].
Though our results suggest that our exercise interven-
tion did not have a statistically significant effect on pain,
these should be interpreted cautiously. The non-significant
trend for patients to report less pain post-exercise interven-
tion as compared to pre-exercise intervention may have
been the result of insufficient power. Hence, it is necessary
to keep in mind that patients’ levels of pain decreased post-
exercise intervention, and that they were lower than their
pre-neoadjuvant chemoradiation therapy levels. Further,
compared to reference data published for patients with rec-
tal cancer [30], patients in this study reported lower levels
of pain post-exercise intervention. Thus, it is recommended
that studies with larger samples sizes be conducted to as-
sess the extent to which exercise may have an impact on
pain during this time in this population.
In contrast to previous research that suggests exercise
can reduce anxiety, depression, and sleep disturbances
during and post-treatment in adults with cancer [38], we
did not find statistically significant improvements in in-
somnia or mental health perceptions. Neither insomnia
nor mental health perceptions worsened during neoadju-
vant chemoradiation therapy, and levels were compar-
able to normative levels [30]. This may have left less
room for improvement than if patients had high levels
of insomnia and poor mental health perceptions after
undergoing neoadjuvant chemoradiation therapy. Alter-
natively, the non-significant effects of exercise on these
outcomes might be due to the short duration of our
intervention (i.e., 6 weeks). Based on previous reports
[41], longer interventions might be necessary to change
mental health perceptions and insomnia. Patients could
have also been taking pharmaceuticals or have received
psychological therapy (data not collected) to manage
their insomnia and/or mental health issues [42], which
may have confounded the effects of exercise on these
outcomes. Last, the measures used, though valid and re-
liable, might not have been sensitive enough to capturechanges in these two patient-reported outcomes. For in-
stance, insomnia was only measured using one item,
which may fail to capture insomnia symptoms along sev-
eral dimensions (i.e., severity, duration, and impact).
Assessing insomnia using questionnaires that capture
the nature, severity, and impact of insomnia may be
more effective for determining if exercise has an impact
on insomnia. As well, previous studies have shown that
adults with cancer are likely to experience unanticipated
fear, anxiety, and psychological stress about major sur-
gery [5]. The mental health summary score derived from
the RAND 36-Item Health Survey might not be sensitive
to measuring these specific cancer-related mental health
issues (e.g., pre-operative anxiety) that might have been
affected by exercise. These possible explanations should
be investigated in future research.
Limitations
Perhaps the most significant limitation of this study is
the small sample size of the control group that could
have introduced Type II error when testing for differ-
ences between the exercise group and the control group.
Indeed, power calculations were only made to determine
the sample size required to detect a minimum difference
in oxygen uptake at lactate threshold of 1.5 ml kg−1 min
−1 and a SD of 1.1 ml kg−1 min−1 [22], not QoL. Relat-
edly, because the sample size was small and the data
were not normally distributed for three variables, non-
parametric statistical tests that do not require the as-
sumptions of normality be met were used. However, it
should be noted that non-parametric tests are more con-
servative and are appropriate for hypothesis testing
when the sample size is small. Other limitations include
the reliance on a convenience sample, our inability to re-
port the rate of recruitment because the number of pa-
tients eligible was not recorded, and the non-
randomization. The latter increases the likelihood of
there being differences between the exercise group and
the control group in factors (known and unknown) that
could affect the outcomes we assessed. Also, this study
has the potential for ascertainment bias due to the fact
that patients were given a choice to participate in the ex-
ercise intervention. Consequently, the effects observed
may be biased upwards. A final limitation is the lack of
follow-up data to determine if the observed improvements
were maintained over time and whether pre-operative
exercise reduced the incidence of post-operative compli-
cations. Thus, a larger, adequately powered randomized
controlled trial with long-term follow-ups is needed to
compare the effects of exercise post-neoadjuvant che-
moradiation therapy/prior to surgical resection on pain,
fatigue, insomnia, and physical and mental health per-
ceptions, in comparison to usual care, in patients with
locally advanced stage rectal cancer.
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Pain, fatigue, and insomnia are prevalent and disturbing
side effects of treatment for advanced rectal cancer.
Furthermore, treatment for advanced rectal can result
in diminished health perceptions and QoL. The notion
that exercise has a greater effect on self-reported pain,
fatigue, insomnia, and health perceptions than usual
care was not confirmed in this study. Nevertheless, we
did observe an increase in physical health perceptions
and a decrease in levels of fatigue post-exercise inter-
vention for patients in the exercise group. We also
found small, but not statistically significant, decreases
in levels of pain post-exercise intervention for these pa-
tients. In light of the limitations associated with this
study, it is important that a larger randomized con-
trolled trial be conducted to assess the effectiveness of
exercise in comparison to usual care, and to provide
precise estimates of the effects of exercise on key
patient-reported outcomes. Such a study would provide
valuable insight into the extent to which pre-operative
exercise is effective in treating patients’ side effects and
promoting improvements in the quality of their lives
above and beyond usual care.
Endnotes
1Changes in objectively-measured physical fitness are
reported elsewhere [22, 23].
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